← Company directoryNYSE · NYSE
Teva Pharmaceutical Industries Ltd.
TEVAA primary-source company identity page built for fast discovery, filing verification and consistent financial research.
ANALYSIS ROUTE
Four checks before any decision
Business model
Understand how the company earns and where demand originates.
Revenue and margin
Compare equivalent periods; separate growth from profitability.
Debt and cash flow
Test balance-sheet resilience and cash conversion.
Valuation and risk
Use sector peers, scenarios and explicit risk limits.
Dates connected to this company
Confirmed events from the FinRatex financial calendar, linked to their named sources.
Teva third-quarter 2026 results
Teva will release its third-quarter 2026 financial results on November 3 at 7:00 AM EST / 3:00 PM Istanbul.
Teva ↗Teva third-quarter earnings call
Teva management will discuss the third-quarter results in a conference call and webcast on November 3 at 8:00 AM EST / 4:00 PM Istanbul.
Teva ↗More NYSE records
Alphabetically adjacent directory records for faster navigation; this is not a peer or valuation classification.
DATA STATUS
Open official filings ↗Issuer source connected
A dash means standardized data is unavailable. Always check the filing period, currency and accounting scope.